Carole Ho, Chief Medical Officer at Denali Therapeutics Inc. (DNLI), sold 5,092 shares at $49.91 ($252K) on 2021-08-19, disclosed to the SEC on 2021-08-23.
Seasonal sale ($252k) by Chief Medical Officer — this insider has traded DNLI in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.31 | 1,402 | $69K | 27.4% |
| 2 | $49.31 | 1,402 | $69K | 27.4% |
| 3 | $49.91 | 1,144 | $57K | 22.6% |
| 4 | $49.91 | 1,144 | $57K | 22.6% |
| Total | $49.58 avg | 5,092 | $252K | 100% |
| Filing → |
| DNLI | SELL | 2024-08-22 | $1.1M | — | Filing → |
| DNLI | SELL | 2024-08-15 | $107K | — | Filing → |
| DNLI | SELL | 2024-02-15 | $73K | — | Filing → |